Last reviewed · How we verify
donepezil treatment
At a glance
| Generic name | donepezil treatment |
|---|---|
| Sponsor | Associação Fundo de Incentivo à Pesquisa |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Donepezil Versus Non-drug Treatment in Alzheimer's Disease. (PHASE3)
- Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease (NA)
- Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease (NA)
- Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) (PHASE1)
- Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease (EARLY_PHASE1)
- Masitinib in Patients With Mild Alzheimer's Disease (PHASE3)
- Progress of Mild Alzheimer's Disease in Participants on Acupuncture Versus Sham Acupuncture (NA)
- Donepezil and Cognitive Training for Alcohol Use Disorder (AUD) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- donepezil treatment CI brief — competitive landscape report
- donepezil treatment updates RSS · CI watch RSS
- Associação Fundo de Incentivo à Pesquisa portfolio CI